Lithium chloride-induced cardiovascular changes in rabbits are mediated by adenosine triphosphate-sensitive potassium channels

Pharmacological Research

Volumn 39, Issue 4, 1999, Pages 275-282

  Abdel Zaher, Ahmed O ^a   Abdel Rahman, Mahmoud M ^a  

^a Assiut University Faculty of Medicine   (Egypt)

Author keywords

Aortic strips; Glibenclamide; Lithium chloride; Potassium channels

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIAZOXIDE; GLIBENCLAMIDE; LITHIUM CHLORIDE; NORADRENALIN; POTASSIUM CHANNEL; POTASSIUM ION; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; HEART MUSCLE CONTRACTILITY; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RABBIT;

EID: 0033119160     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0445     Document Type: Article

References (42)

1. Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet 1995; 29: 172-91.
2. Gershon S, Shopsin B. Lithium: Its Role in Psychiatric Research and Treatment. New York: Plenum Press, 1973: 108-71.
3. Berkowitz DE, Richardson C, Elliott DA, Leslie JB, Schwinn DA. Hypotension resistant to therapy with receptor agonists complicating cardiopulmonary bypass: Lithium as a potential cause. Anesth Analg 1996; 82: 1082-5.
4. Humbert G, Fillastre JP, Leroy J. Intoxication par le lithium. Sem Hop Paris 1974; 50: 509-12.
5. Misu Y, Pre- and postsynaptic origin of lithium induced blockade on adrenergic transmission in rabbit heart. Jpn J Pharmacol 1976; 25: 787-92.
6. Riccuitti MA, Lisi KR, Damato AN. A metabolic basis for the electrophysiological effects of lithium. Circulation 1971; 44: 217-23.
7. Wellens HJ, Cats M, Duren DR. Symptomatic sinus node abnormalities following lithium carbonate therapy. Am J Med 1975; 59: 285-91.
8. Horgan JH, Ford GD, Proctor JD. The effect of prophylactic and therapeutic administration of lithium on ventricular tachycardia. Arch Int Pharmacodyn 1974; 207: 77-85.
9. Tilkian R, Schroeder A, Kao R, Hultgren N. Cardiovascular effects of lithium in man. Am J Med 1976; 61: 665-70.
10. + channels in cardiac muscle. Nature 1983; 305: 147-8.
11. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol 1990; 259: C3-18.
12. Nichols CG, Lederer WJ. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol 1991; 261: H1675-86.
13. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995; 268: C799-822.
14. + channel-opening drugs. Am J Physiol 1995; 269: C525-45.
15. Adams H. Adenosine 5′-triphosphate determination with phosphoglycerate kinase. In: Methods of Enzymatic Analysis. Bergmeyer HU, ed. New York: Academic press, 1963: 539-43.
16. El-Koussi AA, Afifi AM, Abdel-Rahman MM. Mechanism of lithium action on the adrenergic function. Pharmacol Res Commun 1983; 15: 397-407.
17. Fann WE, Davis JM, Janowsky DS, Cavanaugh JH, Kaufmann JS, Griffith JD, Oates JA. Effects of lithium on adrenergic function in man. Clin Pharmacol Ther 1972; 13: 71-7.
18. Frazer A, Hancock A, Merdels J, Macintire R. Effect of lithium on catecholamine-induced responses in the isolated perfused guinea pig heart. Biol Psychiatry 1972; 5: 79-87.
19. + channels in arterial smooth muscle. Science 1989; 245: 177-80.
20. + channels from aortic smooth muscle incorporated into planar lipid bilayers. Am J Physiol 1991; 261: H604-9.
21. Babenko AP, Vassort G. Purinergic facilitation of ATP-sensitive potassium current in rat ventricular myocytes. Br J Pharmacol 1997; 120: 631-8.
22. Roden DM, George AL. Structure and function of cardiac sodium and potassium channels. Am J Physiol 1997; 273: H511-25.
23. Grover GJ. Protective effects of ATP-sensitive potassium channel openers in experimental myocardial ischemia. J Cardiovasc Pharmacol 1994; 24: S18-27.
24. ATP channels. Am J Physiol 1997; 273: H2804-10.
25. Liu B, Goylan F, McCullough JR, Vassale M. Electrophysiological and antiarrhythmic effects of the K-channel opener, BRL 34915, in cardiac purkinje fibers. Drug Dev Res 1988; 14: 123-39.
26. + channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. J Pharmacol Exp Ther 1989; 250: 261-71.
27. + channels? Trends Pharmacol Sci 1993; 14: 332-7.
28. Ashcroft SJH, Ashcroft FM. Properties and functions of ATP-sensitive K-channels. Cell Signalling 1990; 2: 197-214.
29. + current in canine coronary smooth muscle cells. Pfluegers Arch 1994; 427: 110-20.
30. + channel in mouse pancreatic cell. Pfluegers Arch 1986; 407: 493-9.
31. + channels in guinea pig cardiac myocytes. Pfluegers Arch 1989; 414: 669-75.
32. + channels in cardiac muscle by the sulphonylurea drug gliben-clamide. J Pharmacol Exp Ther 1992; 261: 540-5.
33. + channels. Br J Pharmacol 1995; 115: 381-2.
34. Loeffler C, Quast U. Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta. Br J Pharmacol 1997; 120: 476-80.
35. Singh BN, Effrodt G, Peter CT. Verapamil: A review of its pharmacological properties and therapeutic use. Drugs 1978; 15: 169-91.
36. Winquist RJ, Heaney LA, Wallace AA, Baskin EP, Stein RB, Garcia ML, Kaczarowski GJ. Glyburide blocks the relaxation response to BRL 34915 [cromakalim], minoxidil sulfate and diazoxide in vascular smooth muscle. J Pharmacol Exp Ther 1989; 248: 149-56.
37. Yoshitake K, Hirano K, Kanaide H. Effects of glibenclamide on cytosolic calcium concentrations and on contraction of the rabbit aorta. Br J Pharmacol 1991; 102: 113-18.
38. Mc Kusick VA. The effect of lithium on the electocardiogram of animals and relation of these effects to the ratio of the intracellular and extracellular concentration of potassium. J Clin Invest 1954; 33: 598-603.
39. Harrison CD, Cooper G, Zujko KJ. Myocardial and mitochondrial function in potassium depletion cardiomyopathy. J Mol Cell Cardiol 1972; 4: 633-938.
40. Ettinger PO, Regan TJ, Oldewurte HA. Hyperkalemia, cardiac conduction and the electrocardiogram. Rev Am Heart 1974; 88: 360-72.
41. Coldwell MC, Howlett DR. Specificity of action of the novel antihypertensive agent BRL 34915, as a potassium channel activator. Biochem Pharmacol 1987; 36: 3663-9.
42. 42K efflux by ATP depletion and cromakalim is antagonized by glyburide. Am J Physiol 1991; 260: H848-54.